Literature DB >> 7580816

Acamprosate in alcohol dependence: how does it work?

J Littleton1.   

Abstract

Acamprosate is a relatively new drug that appears to be clinically useful in the treatment of alcohol dependence. Although it has proved effective in reducing relapse into drinking in clinical trials its exact mechanism of action is uncertain. Evidence is presented that the drug does not act in any of the conventional ways to reduce alcohol intake and it is proposed that it may be a novel kind of agent that suppresses "craving". On the basis of its known pharmacological effects in pre-clinical studies it is suggested that acamprosate may reduce craving that is associated with conditioned withdrawal. In addition to the potential therapeutic value of acamprosate, the drug may be useful because work directed toward understanding its mechanism of action may shed light on some of the fundamental processes that govern alcohol abuse and relapse in weaned alcohol dependent patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7580816     DOI: 10.1046/j.1360-0443.1995.90911793.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  43 in total

1.  Increased consumption but not operant self-administration of ethanol in mice lacking the RIIbeta subunit of protein kinase A.

Authors:  Frank M Ferraro; Dennis R Sparta; Darin J Knapp; George R Breese; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2006-05       Impact factor: 3.455

2.  Does Acamprosate Really Produce its Anti-Relapse Effects via Calcium? No Support from the PREDICT Study in Human Alcoholics.

Authors:  Karl Mann; Sabine Hoffmann; Cornelius R Pawlak
Journal:  Neuropsychopharmacology       Date:  2016-02       Impact factor: 7.853

Review 3.  Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models.

Authors:  Megan M Yardley; Lara A Ray
Journal:  Addict Biol       Date:  2016-02-01       Impact factor: 4.280

Review 4.  Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function.

Authors:  Bankole A Johnson
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

5.  Involvement of the AMPA receptor GluR-C subunit in alcohol-seeking behavior and relapse.

Authors:  Carles Sanchis-Segura; Thilo Borchardt; Valentina Vengeliene; Tarek Zghoul; Daniel Bachteler; Peter Gass; Rolf Sprengel; Rainer Spanagel
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

6.  Acamprosate modulates alcohol-induced hippocampal NMDA receptors and brain microsomal Ca2+-ATPase but induces oxidative stress in rat.

Authors:  Ali Metehan Calişkan; Mustafa Naziroğlu; Abdulhadi Cihangir Uğuz; Ishak Suat Ovey; Recep Sütçü; Ramazan Bal; Sila Calişkan; Ramazan Ozcankaya
Journal:  J Membr Biol       Date:  2010-09-25       Impact factor: 1.843

Review 7.  Alcohol use disorders in adolescents: epidemiology, diagnosis, psychosocial interventions, and pharmacological treatment.

Authors:  Duncan B Clark; Oscar Bukstein; Jack Cornelius
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 8.  Relapse Prevention in Alcoholism : Recent Advances and Future Possibilities.

Authors:  M Soyka
Journal:  CNS Drugs       Date:  1997-04       Impact factor: 5.749

9.  Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin.

Authors:  Barbara J Mason; John M Light; Lauren D Williams; David J Drobes
Journal:  Addict Biol       Date:  2008-10-09       Impact factor: 4.280

10.  Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients.

Authors:  Roel Verheul; Philippe Lehert; Peter J Geerlings; Maarten W J Koeter; Wim van den Brink
Journal:  Psychopharmacology (Berl)       Date:  2004-08-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.